Dopamine receptors in human brain: Autoradiographic distribution of D1 sites
暂无分享,去创建一个
J. Palacios | Á. Pazos | R. Cortės | B. Gueye | A. Probst | A. Probst | J. M. Palacios | A. Pazos | R. Cortés | B. Gueye | A. Probst
[1] O. Hornykiewicz. 9 – Dopamine and Its Physiological Significance in Brain Function , 1972 .
[2] O. Hornykiewicz,et al. OCCURRENCE AND DISTRIBUTION OF AROMATIC l‐AMINO ACID (l‐DOPA) DECARBOXYLASE IN THE HUMAN BRAIN , 1972, Journal of neurochemistry.
[3] Michael J. Schmidt,et al. Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old and aged rats , 1978, Brain Research.
[4] M. Starr,et al. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse Implications for the roles of D1 and D2 receptors , 1986, Neuropharmacology.
[5] F E Bloom,et al. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. , 1978, Annual review of neuroscience.
[6] J. Palacios,et al. Mapping receptors in the human brain , 1986, Trends in Neurosciences.
[7] B. Berger,et al. Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon Immunocytochemical localization and relationships , 1983, Journal of the Neurological Sciences.
[8] P. Davies,et al. REGIONAL DISTRIBUTION OF ENZYMES ASSOCIATED WITH NEUROTRANSMISSION BY MONOAMINES, ACETYLCHOLINE AND GABA IN THE HUMAN BRAIN , 1978, Journal of neurochemistry.
[9] P. Mcgeer,et al. Aging and extrapyramidal function. , 1977, Archives of neurology.
[10] J. Waddington,et al. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide. , 1985, European journal of pharmacology.
[11] J. Pearson,et al. Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase , 1983, Neuroscience.
[12] Jan Voogd,et al. The human central nervous system : a synopsis and atlas , 1978 .
[13] J. Larsen,et al. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. , 1984, Life sciences.
[14] J. C. Stoof,et al. Two dopamine receptors: biochemistry, physiology and pharmacology. , 1984, Life sciences.
[15] P. Mcgeer,et al. Aging and neurotransmitter systems. , 1980, Advances in biochemical psychopharmacology.
[16] H. Sarau,et al. Separation of potent central and renal dopamine agonist activity in substituted 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepines. , 1980, Journal of medicinal chemistry.
[17] C. Finch,et al. [3H]Fluphenazine Binding to Brain Membranes: Simultaneous Measurement of D‐1 and D‐2 Receptor Sites , 1986, Journal of neurochemistry.
[18] J. Hyttel. Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro. , 1981, Life sciences.
[19] J. Hyttel. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390 , 1984, Neuropharmacology.
[20] J. Kebabian,et al. The D1 dopamine receptor: new perspectives , 1986 .
[21] A. Barnett,et al. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. , 1983, The Journal of pharmacology and experimental therapeutics.
[22] P. Beart,et al. Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum , 1985, Neuroscience Letters.
[23] J. Waddington,et al. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum. , 1981, European journal of pharmacology.
[24] E. Spokes,et al. Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue. , 1980, Brain : a journal of neurology.
[25] S. Wyrick,et al. [3H]SCH23390 has the characteristics of a dopamine receptor ligand in the rat central nervous system. , 1984, European journal of pharmacology.
[26] J. Hyttel. SCH 23390 - the first selective dopamine D-1 antagonist. , 1983, European journal of pharmacology.
[27] J. C. Stoof,et al. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum , 1981, Nature.
[28] T. Dawson,et al. D-1 dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390. , 1985, European journal of pharmacology.
[29] J. Kebabian,et al. Multiple receptors for dopamine , 1979, Nature.
[30] P. Mcgeer,et al. DISTRIBUTION OF TYROSINE HYDROXYLASE IN HUMAN AND ANIMAL BRAIN 1 , 1971, Journal of neurochemistry.
[31] B. Berger,et al. Dopamine and methionine-enkephalin in human brain , 1982, Neuroscience Letters.
[32] F. Owen,et al. Characteristics of 3H-cis-flupenthixol binding to calf brain membranes. , 1980, European journal of pharmacology.
[33] G. Gessa,et al. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats. , 1984, European journal of pharmacology.
[34] G. Reynolds,et al. [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease. , 1985, European journal of pharmacology.
[35] C. Marsden,et al. The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset , 1985, Neuroscience Letters.
[36] B. Berger,et al. Catecholaminergic innervation of the septal area in man: Immunocytochemical study using TH and DBH antibodies , 1985, The Journal of comparative neurology.
[37] O. Bugiani,et al. Nerve cell loss with aging in the putamen. , 1978, European neurology.
[38] B. Berger. Histochemical identification and localization of dopaminergic axons in rat and human cerebral cortex. , 1977, Advances in biochemical psychopharmacology.
[39] P. Seeman. Brain dopamine receptors. , 1980, Pharmacological reviews.
[40] J. Waddington,et al. Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol. , 1984, European journal of pharmacology.
[41] B. Bogerts. A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker , 1981, The Journal of comparative neurology.
[42] E. Ongini,et al. Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal. , 1985, Life sciences.
[43] M. Savasta,et al. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors , 1986, Neuroscience.
[44] L. Volicer,et al. Effect of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatum , 1977, Mechanisms of Ageing and Development.
[45] H. Sarau,et al. The central effects of a novel dopamine agonist. , 1978, European journal of pharmacology.
[46] J. Hyttel,et al. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. , 1984, European journal of pharmacology.
[47] J. Rinne,et al. Dopamine D-1 receptors in the parkinsonian brain , 1985, Brain Research.
[48] D. Sibley,et al. The classification of dopamine receptors: relationship to radioligand binding. , 1983, Annual review of neuroscience.
[49] T. Dawson,et al. D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[50] O. DeJesus,et al. Positron tomography of a radio-brominated analog of the D1/DA1 antagonist, SCH 23390. , 1985, European journal of pharmacology.
[51] H. Sarau,et al. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum. , 1985, Life sciences.
[52] J. Palacios,et al. Dopamine receptors in human brain: Autoradiographic distribution of D2 sites , 1989, Neuroscience.
[53] P. H. Andersen,et al. Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo. , 1986, Life sciences.
[54] Y. Agid,et al. Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects. , 1985, European journal of pharmacology.
[55] A. Barnett,et al. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. , 1984, Life sciences.
[56] I. Creese,et al. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum. , 1986, European journal of pharmacology.
[57] P. Davies,et al. REGIONAL DISTRIBUTION OF MONOAMINES AND THEIR METABOLITES IN THE HUMAN BRAIN , 1978, Journal of neurochemistry.
[58] M. Savasta,et al. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390 , 1986, Brain Research.
[59] J. Palacios,et al. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: Brainstem , 1984, Neuroscience.